Favipiravirin Su-Asetonitril İkili Karışımlarında İyonlaşma Sabiti Değerinin Belirlenmesi ve İki Farklı C18 Kolonun Karşılaştırılması

Favipiravirin Su-Asetonitril İkili Karışımlarında İyonlaşma Sabiti Değerinin Belirlenmesi ve İki Farklı C18 Kolonun Karşılaştırılması

Favipiravir (T-705), RNA virüslerinin RNA'ya bağımlı RNA polimerazını seçici ve güçlü bir şekilde inhibe eden bir anti-viral ajandır. Bu bileşiğin kalitatif ve kantitatif analizinde en çok ters faz sıvı kromatografi (RPLC) metodu tercih edilmektedir. Bu metot, asidik ve bazik fonksiyonel grup i...

Full description

Bibliographic Details
Main Authors:	İlkay Konçe, Ümit Ayhan Arzuoğlu, Ebru Çubuk Demiralay
Format:	Article
Language:	English
Published:	Suleyman Demirel University 2023-06-01
Series:	Süleyman Demirel Üniversitesi Fen-Edebiyat Fakültesi Fen Dergisi
Subjects:	favipiravir rplc alıkonma zamanı i̇yonlaşma sabiti hidrofilik bileşik retention time ionization constant hydrophilic compound
Online Access:	https://dergipark.org.tr/tr/download/article-file/2721687

Similar Items

Living with Breakthrough: Two-Dimensional Liquid-Chromatography Separations of a Water-Soluble Synthetically Grafted Bio-Polymer
by: H.C. van de Ven, et al.
Published: (2020-07-01)

Helyum Atomunun İkili Uyarılma-İyonlaşma Rezonans Profillerinin 10o-80o Açı Aralığındaki Değişimlerinin İncelenmesi
by: Zehra Nur Özer, et al.
Published: (2020-11-01)

Quantitative Structure Retention-Relationship Modeling: Towards an Innovative General-Purpose Strategy
by: Priyanka Kumari, et al.
Published: (2023-02-01)

Asetonitril-Su İkili Karışımlarında Piroksikam ve Tenoksikam'ın Potansiyometrik pKa Tayini
by: Ebru Çubuk Demiralay, et al.
Published: (2012-06-01)

Using an Untargeted Metabolomics Approach to Identify Salivary Metabolites in Women with Breast Cancer
by: Daniele Xavier Assad, et al.
Published: (2020-12-01)

Estimation of Solute-Stationary Phase and Solute-Mobile Phase Interactions in the Presence of Ionic Liquids
by: María José Ruiz-Ángel
Published: (2019-08-01)

Effect of favipiravir and an anti-inflammatory strategy for COVID-19
by: Hitoshi Yamamura, et al.
Published: (2020-07-01)

Production and Characterization of ACE Inhibitory and Anti-Diabetic Peptides from Buffalo and Camel Milk Fermented with Lactobacillus and Yeast: A Comparative Analysis with In Vitro, In Silico, and Molecular Interaction Study
by: Ruchita Khakhariya, et al.
Published: (2023-05-01)

A Novel Luminance-Based Algorithm for Classification of Semi-Dark Images
by: Mehak Maqbool Memon, et al.
Published: (2021-09-01)

Metan Molekülünün Elektron Etkisiyle İyonlaşma Dinamiğinin Çakışma Tekniği ile İncelenmesi
by: Nimet IŞIK, et al.
Published: (2014-12-01)

Studies on the Effects of Process Conditions on Separation of B1, B2 and B3 Vitamin Mixture Using HILIC and RPLC Chromatography
by: Marcin Chutkowski, et al.
Published: (2022-07-01)

Site-specific N-glycosylation characterization and allergenicity analysis of globulin-1 S allele from wheat
by: Linglin Fu, et al.
Published: (2023-09-01)

Favipiravir in Therapy of Viral Infections
by: Ryta Łagocka, et al.
Published: (2021-01-01)

Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand
by: Pinyo Rattanaumpawan, et al.
Published: (2022-06-01)

Hematological Malignancy Patients, COVID-19, and Favipiravir
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-12-01)

Follow-up of Favipiravir-Induced Nail Fluorescence: Implications for Nail and Drugs
by: Hüsna Güder, et al.
Published: (2023-01-01)

A case report of urticaria as a rare side effect of favipiravir in a patient with COVID-19
by: Amit Kumar, et al.
Published: (2021-01-01)

Progress and Challenges in Quantifying Carbonyl-Metabolomic Phenomes with LC-MS/MS
by: Yuting Sun, et al.
Published: (2021-10-01)

Comparisons of treatment protocols for SARS-COV-2 in early pandemic: Single center experience ın Turkey
by: Tuncer Şimşek, et al.
Published: (2022-03-01)

Experimental Studies on Some Drugs Used in Covid-19 Treatment (Favipiravir and Dexamethasone) in Albino Rats
by: Moustafa S. Abou El-Fetouh, et al.
Published: (2023-12-01)

Experimental Studies on Some Drugs Used in Covid-19 Treatment (Favipiravir and Dexamethasone) in Albino Rats
by: Moustafa S. Abou El-Fetouh, et al.
Published: (2023-12-01)

Liver Injury in Favipiravir-Treated COVID-19 Patients: Retrospective Single-Center Cohort Study
by: Amal Oweid Almutairi, et al.
Published: (2023-02-01)

Evaluation of the effect of favipiravir on patients with COVID-19
by: Alireza Kamali, et al.
Published: (2023-01-01)

Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
by: Mohamed S. Imam, et al.
Published: (2023-07-01)

Perbandingan Angka Kematian Terapi Antiviral Favipiravir dan Remdesivir pada Pasien COVID-19 Di RSUP Dr. Sardjito Yogyakarta
by: Nova Satriyani, et al.
Published: (2023-01-01)

The Effectiveness and Safety of Favipiravir in COVID-19 Hospitalized Patients at Tertiary Referral Hospital, Bali, Indonesia
by: Herni Damayanti, et al.
Published: (2021-11-01)

Mucocutaneous adverse effects of remdesivir and favipiravir in patients with Covid-19 infection: A systematic review
by: Pradeep Balasubramanian, et al.
Published: (2022-01-01)

Does Favipiravir Reduce Mortality in Patients with COVID-19 ARDS and Severe Pneumonia?
by: Khin Zar Li Aung, et al.
Published: (2021-12-01)

Efektivitas Efikasi Pemberian Antivirus Favipiravir pada Pasien Covid-19: Evidence Based Case Report
by: Bastomy Eka Rezkita, et al.
Published: (2022-06-01)

DFT/QTAIM analysis of favipiravir adsorption on pristine and silicon doped C20 fullerenes
by: Alver Özgür, et al.
Published: (2019-10-01)

Favipiravir-induced fever in coronavirus disease 2019: A report of two cases
by: Hiroyuki Takoi, et al.
Published: (2020-12-01)

Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates
by: Kamal Singh, et al.
Published: (2022-10-01)

Clinical Symptoms and Treatment Outcomes of COVID-19 Patients with Stroke
by: Oskar Yuda Daud, et al.
Published: (2024-03-01)

Drug Synergism of Anticancer Action in Combination with Favipiravir and Paclitaxel on Neuroblastoma Cells
by: Hasan Turkez, et al.
Published: (2023-12-01)

Anti-Influenza Virus Study of Composite Material with MIL-101(Fe)-Adsorbed Favipiravir
by: Mengyuan Xu, et al.
Published: (2022-03-01)

Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV
by: Hikaru Fujii, et al.
Published: (2022-07-01)

Favipiravir Inhibits Zika Virus (ZIKV) Replication in HeLa Cells by Altering Viral Infectivity
by: Evelyn J. Franco, et al.
Published: (2023-04-01)

Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus
by: Jennifer Mayor, et al.
Published: (2021-06-01)

Favipiravir Inhibits Mayaro Virus Infection in Mice
by: Michèle Bengue, et al.
Published: (2021-11-01)

Pharmacokinetic Interaction Between Favipiravir and Amlodipine in Hypertensive Local Rabbits (Oryctolagus cuniculus)
by: Ali I Al-ameedi, et al.
Published: (2023-06-01)